November 30, 2017
BURLINGTON, Mass., November 29, 2017 (GLOBE NEWSWIRE) – scPharmaceuticals Inc. (the “Company” or “scPharmaceuticals”) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs, today announced it has issued an additional 894,968 shares of common stock at the...


Maude has become the stereotypical migraine patient – but it’s not quite the true picture
31. July 2020
Ancient DNA throws a ‘scientific hand grenade’ into the discussion about the arrival of humans in North America
23. July 2020
Danish researchers map key disease mechanism – and describe a completely new protein
20. July 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge